Treatment of human viral infections

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 51, 514261, 514934, A61K 31705, A61K 3152

Patent

active

056839901

ABSTRACT:
Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof. Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose. Additionally, there is disclosed the treatment of Kaposi's sarcoma with 3'-azido-3'-deoxythymidine (AZT) and the synergistic activity in the treatment of humans infected with HTLV-III of AZT and interferon as well as AZT and acyclovir and AZT and 2-amino-9-(2-hydroxyethoxymethyl)purine or an ester thereof.

REFERENCES:
patent: 4360522 (1982-11-01), Schaeffer
patent: 4649140 (1987-03-01), Schaeffer
patent: 4710492 (1987-12-01), Lin et al.
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4857511 (1989-08-01), Rideout et al.
Yarchoan et al, Lancel (8481) pp. 575-580, Mar. 1986.
Surbone et al, Anal of Internal Medicine 108 pp. 534-540 (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of human viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of human viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of human viral infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1833136

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.